Introduction
Cholestatic drug reactions are not uncommon but are usually mild and reversible. A patient is described who died as a result of an unremitting intrahepatic cholestasis which may have been related to treatment with the benzodiazepine hypnotic, triazolam.
Case report
A 44-year-old policeman presented to the General Hospital, Hartlepool, in September 1980 with a one-month history of painless jaundice and severe pruritus. In 1974 he had had a successful resection of a small ampullary carcinoma and was extremely well when finally discharged from out-patient follow-up in 1979. In April 1980 his general practitioner prescribed triazolam 0-25 mg at night for insomnia which was taken 2 or 3 times/week until presentation. In June 1980 he was found to be in atrial fibrillation and was given digoxin 025 
Discussion
The clinical picture of deep painless jaundice with intense pruritus was strongly suggestive of obstruction and, although the alkaline phosphatase was only moderately elevated histology confirmed marked cholestasis. The findings are consistent with drug-induced disease. There was no history of excessive alcohol intake, large duct obstruction was ruled out and the laboratory and pathological findings make other diagnoses such as hepatitis or primary biliary cirrhosis extremely unlikely.
The relationship between the fatal liver damage and triazolam is conjectural. The authors know of no other reports of liver disease associated with the drug but it has been introduced only recently to the market. Cholestasis is a recognized association with other benzodiazepines, including chlordiazepoxide and diazepam (Davies, 1977) and flurazepam (Franks and Jacobs, 1975) but is usually a benign condition (Davies, 1977) . It has not been recorded with either digoxin or Moduretic. There is one well documented case of reversible cholestasis associated with chlorothiazide treatment (Drerup et al., 1958) but these drugs have been in use for many years and diuretic-induced liver disease must be extremely rare (Davies, 1977 
